Uncategorized

Moderation on Licorice

The US Food and Drug Administration warns moderation on licorice, or liquorice, a low-growing shrub mostly grown for commercial use in Greece, Turkey, and Asia. It is in black licorice and has been used as a treatment for heartburn, stomach ulcers, bronchitis, sore throat, cough and some infections caused by viruses, such as hepatitis. Licorice contains the compound glycyrrhizin. Glycyrrhizin can lower potassium levels, and cause abnormal heart rhythms, high blood pressure, edema (swelling), lethargy, and congestive heart failure. It can interact with some medications, herbs and dietary supplements. Many “licorice” or “licorice flavor” products manufactured in the US do not contain any licorice. Instead, they contain anise oil, which has the same smell and taste. If you have been eating a lot of black licorice and have an irregular heart rhythm or muscle weakness, stop eating it immediately and contact your healthcare provider. Source: https://www.fda.gov/

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

14 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

20 hours ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

4 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

6 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

7 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.